Clinical Pediatric Endocrinology is a prestigious journal dedicated to advancing the field of pediatric endocrinology, published by the Japanese Society of Pediatric Endocrinology. With a respectable ISSN 0918-5739 and E-ISSN 1347-7358, this journal serves as a critical platform for innovative research spanning various aspects of endocrine disorders in children, including diabetes and metabolic conditions. Although it does not currently offer open access, it remains highly relevant in its category, being ranked in Q4 and Q3 tiers across multiple specialties as of 2023. With a publication history that spans from 1992 to 2024, this journal has contributed significantly to the literature, as evidenced by its inclusion in prominent databases. It invites submissions from researchers and practitioners worldwide, aiming to facilitate knowledge sharing and improve clinical practices in pediatric endocrinology. For those dedicated to enhancing care outcomes in children with endocrine disorders, Clinical Pediatric Endocrinology provides essential insights and fosters a community of engaged professionals.

Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.

CONGENITAL ANOMALIES is a notable journal published by WILEY, dedicated to advancing the understanding of congenital disorders and anomalies through high-quality research and clinical insights. With an ISSN of 0914-3505 and an E-ISSN of 1741-4520, this journal has been a key resource for professionals in the fields of pediatrics, embryology, and developmental biology since its inception in 1973, although coverage discontinued in Scopus after 2019 due to evolving standards in publication. The journal is ranked in the 48th percentile in the domain of pediatrics, as well as in the 26th and 14th percentiles respectively for embryology and developmental biology, placing it among respected publications in its category. Although it does not currently offer open access options, its contributions remain vital for researchers, healthcare professionals, and students seeking up-to-date information on congenital anomalies, their origins, and potential interventions. With a commitment to fostering knowledge in this critical area of health science, CONGENITAL ANOMALIES continues to play an important role in the intersection of scientific research and clinical practice.

Molecular Diagnosis & Therapy, published by ADIS INT LTD, is a premier journal dedicated to the cutting-edge fields of genetics, molecular medicine, and pharmacology. With a strong emphasis on the translation of molecular insights into innovative therapeutic strategies, this journal serves as a vital resource for researchers, clinicians, and students aiming to stay at the forefront of medical and scientific advancements. The journal boasts an impressive standing in its categories, holding a Q1 ranking in Genetics, Medicine (miscellaneous), and Pharmacology, alongside a Q2 classification in Molecular Medicine for 2023, reflecting its influential contributions to the scientific community. Indexed in Scopus, it occupies distinct positions in its respective fields, ranked #77 in Genetics and Pharmacology, and #53 in Molecular Medicine, highlighting its robust impact factor and scholarly influence. Although it is not open access, the journal ensures widespread dissemination of valuable research, promoting enhanced understanding of molecular diagnostic techniques and therapeutic interventions. Since its inception in 2001, and continuing through to 2024, Molecular Diagnosis & Therapy remains an essential platform for disseminating vital research findings, fostering academic collaboration, and driving forward the dialogue in molecular diagnostics and treatment methodologies.

Application of Clinical Genetics is a premier open-access journal published by Dove Medical Press Ltd., dedicated to advancing the field of clinical genetics since its inception in 2008. Based in New Zealand, this journal has established itself as a significant resource for researchers, clinicians, and students alike, contributing to the body of knowledge in both genetic medicine and clinical applications. With an impact factor reflecting its contributions to the field, the journal holds positions in the Q2 and Q3 quartiles of the 2023 Genetics categories, showcasing its relevance and scientific merit. Furthermore, it ranks #43 out of 99 in Clinical Genetics and #153 out of 347 in Biochemistry, Genetics, and Molecular Biology, indicating robust performance amongst its peers. The journal’s broad scope, encompassing various aspects of clinical genetics, ensures that it remains at the forefront of critical discussions, innovative research, and applications essential for the progression of personalized medicine. Researchers and professionals are encouraged to explore its openly accessible content that fosters collaboration and the sharing of knowledge in this dynamic and rapidly evolving field.

JOURNAL OF MEDICAL GENETICS, published by the BMJ PUBLISHING GROUP, stands as a premier platform in the field of genetics, focusing on both fundamental genetic research and its clinical applications. With a distinctive legacy dating back to 1965 and a significant role in advancing the understanding of genetic disorders, this journal has established itself in the top tiers with a commendable Q1 category ranking in both Genetics and Clinical Genetics as of 2023. The journal's impact is underscored by its Scopus rankings, placing it among the leading journals in the fields of medicine and genetics. Researchers and practitioners are drawn to its rigorous peer-review process and its commitment to disseminating high-quality research findings, critical reviews, and innovative clinical practices. While it is not an open-access journal, the insights provided are invaluable for anyone looking to deepen their knowledge or contribute to the burgeoning field of medical genetics.

Genome Research, published by Cold Spring Harbor Laboratory Press, stands as a premier journal in the field of genetics, featuring rigorous peer-reviewed research that explores the complexities of genome organization and function. With an impressive Q1 ranking in both Genetics and Clinical Genetics according to the 2023 category quartiles, this journal effectively bridges the gap between fundamental genetic science and its clinical applications. Its significance is further highlighted by its Scopus rankings, where it ranks #6 out of 99 in Clinical Genetics and #27 out of 347 in Biochemistry, Genetics, and Molecular Biology, showcasing its broad influence and access to cutting-edge discoveries. Researchers and professionals can look forward to a diverse array of articles that cover genomic technologies, bioinformatics, and translational genomics. Although not currently open access, the wealth of information available in each issue makes it an invaluable resource for anyone engaged in genetic research and applications.

The Journal of Genetics and Genomics, published by SCIENCE PRESS in China, stands as a significant contributor to the fields of Genetics and Molecular Biology. With an ISSN of 1673-8527 and E-ISSN 1873-5533, this esteemed journal has achieved a remarkable reputation, holding a prestigious Q1 ranking in both Genetics and Molecular Biology as of 2023. This journal not only showcases pioneering research but also fosters vital discussions on contemporary challenges and innovations within genomic sciences. As part of its commitment to facilitating scientific advancement, the journal encompasses a range of research articles, reviews, and short communications, all aiming to illuminate the complexities of genetic structures and functions from 2007 to 2024. Researchers, professionals, and students alike are encouraged to engage with its content, which ranks favorably in Scopus—placing it within the top tier of its categories. Join the community of academic excellence and explore the latest findings that shape our understanding of genomics.

NEUROGENETICS is a distinguished journal published by SPRINGER, focusing on the intersection of genetics and neuroscience. With its ISSN 1364-6745 and E-ISSN 1364-6753, this journal has been a vital resource in the fields of cellular and molecular neuroscience and genetics since its establishment in 1997. As of 2023, it is ranked Q3 in Cellular and Molecular Neuroscience and Q2 in both Genetics and Clinical Genetics, reflecting its growing influence and importance in these areas. Although not an open-access journal, it provides significant insights and research findings that contribute to advancing our understanding of genetic influences on neural function and disease. Based in Germany with an address at ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES, NEUROGENETICS serves as a crucial platform for researchers, professionals, and students alike to explore innovative studies that are essential for the future of neuroscience and genetics. With its continuous commitment to high-quality research, the journal aims to foster collaboration and knowledge dissemination among the scientific community.

CURRENT ISSUES IN MOLECULAR BIOLOGY, published by MDPI, serves as an essential forum for researchers and professionals in the rapidly evolving field of molecular biology. Established in 1999 and operating under an Open Access model, this journal not only shares high-quality research but also encourages a vibrant exchange of ideas across various disciplines, including medicine and microbiology. With an impressive trajectory leading into 2024, it has earned its place in the Q2 quartile for both Medicine (miscellaneous) and Microbiology, emphasizing its relevance and impact in these areas. The journal’s commitment to disseminating cutting-edge findings is reflected in its diverse coverage of topics, from molecular genetics to microbial interactions. Operating from its home base in Basel, Switzerland, CURRENT ISSUES IN MOLECULAR BIOLOGY is positioned to contribute significantly to the academic landscape, making it indispensable for those seeking to advance their understanding and research within the life sciences.